Optimization of formulation components and characterization of large respirable powders containing high therapeutic payload (Q51105104)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published in January 2006

Language	Label	Description	Also known as
English	Optimization of formulation components and characterization of large respirable powders containing high therapeutic payload	scientific article published in January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

Optimization of formulation components and characterization of large respirable powders containing high therapeutic payload (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

Ambikanandan Misra

3

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

author name string

Bijay Kumar Padhi

1

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

Mahavir B Chougule

2

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

Pharmaceutical Development and Technology

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

11

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

4

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

465-475

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

A comparison of peak sputum tobramycin concentration in patients with cystic fibrosis using jet and ultrasonic nebulizer systems. Aerosolized Tobramycin Study Group.

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

The formulation of powder inhalation systems containing a high mass of nedocromil sodium trihydrate

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Dry powder inhalation of antibiotics in cystic fibrosis therapy, part 1: development of a powder formulation with colistin sulfate for a special test inhaler with an air classifier as de-agglomeration principle

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

A new agglomerated KSR-592 beta-form crystal system for dry powder inhalation formulation to improve inhalation performance in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Trojan particles: large porous carriers of nanoparticles for drug delivery.

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Protein inhalation powders: spray drying vs spray freeze drying

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Use of solid corrugated particles to enhance powder aerosol performance.

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

A novel spray-drying technique to produce low density particles for pulmonary delivery

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Pulmonary delivery of growth hormone using dry powders and visualization of its local fate in rats

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Controlling molecular weight and degree of deacetylation of chitosan by response surface methodology

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Enhancement of small particle size dry powder aerosol formulations using an ultra low density additive

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols.

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

The relationship between powder inhaler resistance and peak inspiratory conditions in healthy volunteers--implications for in vitro testing.

1 reference

https://api.crossref.org/works/10.1080%2F10837450600939099

21 January 2018

Identifiers

10.1080/10837450600939099

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/17101517

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51105104&oldid=2267868347"